Bausch Health Companies Inc. (BHC): who owns it and who trades it
As of Nov 16, 2026, BHC insiders reported 5 open-market sales worth $507K and 1 purchase worth $15.6M in the last 12 months, with 100% of the sale value made under pre-set 10b5-1 plans. The largest seller was Aimee J. Lenar (President), with $259K. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Bausch Health Companies
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, BHC insiders reported $15.6M of open-market purchases and $507K of sales. 100% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Aimee J. Lenar | President | Sale plan | 36,827 | $7.03 | $259K | Form 4 |
| May 19, 2026 | Frank D. Lee | Director | Sale plan | 24,456 | $5.43 | $133K | Form 4 |
| Mar 3, 2026 | Seana Carson | Vice president | Sale plan | 4,420 | $5.77 | $25.5K | Form 4 |
| Mar 2, 2026 | Seana Carson | Vice president | Sale plan | 6,856 | $5.78 | $39.6K | Form 4 |
| Feb 27, 2026 | Seana Carson | Vice president | Sale plan | 8,388 | $5.95 | $49.9K | Form 4 |
| Nov 25, 2025 | Paulson & Co. Inc. | 10% owner | Purchase | 2.50M | $6.25 | $15.6M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Paulson & Co. Inc. | 10% owner | $15.6M | – | Nov 25, 2025 |
| Aimee J. Lenar | President, US Pharma | – | $259K | Aug 19, 2026 |
| Frank D. Lee | Director | – | $133K | May 19, 2026 |
| Seana Carson | EVP, General Counsel | – | $115K | Mar 3, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
BHC short interest
Low short interest. 2.0% of BHC shares are sold short: about 1 share in 51. Over the last 12 reports the number of shares short went up 24%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 7.41M BHC shares were sold short, 2.0% of the shares outstanding, down 10.1% from the report before. At the average daily volume of 5.99M shares, buying them all back would take about 1.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 7.41M | 1.98% | -10% | 5.99M | 1.2 |
| Oct 15, 2026 | 8.24M | 2.20% | -2% | 1.98M | 4.2 |
| Sep 30, 2026 | 8.40M | 2.25% | -3% | 1.74M | 4.8 |
| Sep 15, 2026 | 8.63M | 2.31% | +5% | 2.82M | 3.1 |
| Aug 31, 2026 | 8.22M | 2.20% | -2% | 2.77M | 3.0 |
| Aug 14, 2026 | 8.42M | 2.25% | +11% | 4.96M | 1.7 |
| Jul 31, 2026 | 7.56M | 2.02% | +3% | 5.06M | 1.5 |
| Jul 15, 2026 | 7.37M | 1.97% | +1% | 1.98M | 3.7 |
| Jun 30, 2026 | 7.33M | 1.96% | -1% | 3.91M | 1.9 |
| Jun 15, 2026 | 7.44M | 1.99% | +22% | 2.21M | 3.4 |
| May 29, 2026 | 6.12M | 1.64% | +3% | 1.60M | 3.8 |
| May 15, 2026 | 5.97M | 1.60% | -6% | 1.75M | 3.4 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Bausch Health Companies company events
Bausch Health Companies filed 15 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 28, 2026.
- Oct 28, 2026ResultsReleased financial results. Filing
- Jul 29, 2026ResultsReleased financial results. Filing
- Jul 1, 2026LeadershipMr. Michael Goettler notified Bausch Health Companies Inc. of his decision to resign from the Board of Directors, effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC. Mr. Goettler’s resignation was not the result of any… Filing
- May 19, 2026VoteReported shareholder vote results. Filing
- Apr 29, 2026ResultsReleased financial results. Filing
- Mar 2, 2026LeadershipBausch Health Companies Inc, took actions to provide for certain earned 2023 performance share unit awards to be paid in cash rather than stock upon vesting, including for named executive officers Thomas Appio and Seana Carson. Filing
- Feb 18, 2026ResultsReleased financial results. Filing
- Jan 23, 2026AnnouncementShared information with investors. Filing
- Jan 13, 2026ResultsReleased financial results. Filing
- Jan 2, 2026AgreementBausch + Lomb Corporation, a subsidiary of Bausch Health Companies Inc., entered into an amendment to the Credit and Guaranty Agreement, dated as of May 10, 2022 (as amended by the First Incremental Amendment, dated as of September 29, 2023, by the Second Incremental Amendment, dated as of November… Filing
- Dec 29, 2025AgreementBausch Health Companies Inc. and its indirect wholly owned subsidiary 1261229 B.C. Ltd. completed the previously announced offers to exchange the Company’s outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028 for up to $1.6 billion of new 10.00% Senior Secured… Filing
- Dec 23, 2025AnnouncementBausch Health Companies Inc. announced the final results and expiration, as of 5:00 p.m., New York City time, on December 23, 2025, of its previously announced offers to exchange the Company’s outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028 for up to $1.6… Filing
- Dec 12, 2025AnnouncementBausch + Lomb Corporation, a subsidiary of Bausch Health Companies Inc., issued a press release announcing that it allocated a $2.8 billion tranche of new term B loans, the proceeds of which will be used to refinance all of its outstanding term B loans due 2031 and its outstanding term B loans due… Filing
- Dec 9, 2025AnnouncementBausch Health Companies Inc. announced the early results, as of 5:00 p.m., New York City time, on December 8, 2025, of the previously announced offers to exchange the Company’s outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028 for up to $1.6 billion of new… Filing
- Nov 24, 2025AnnouncementBausch Health Companies Inc. and its indirect wholly-owned subsidiary 1261229 B.C. Ltd. commenced the offers to exchange the Company’s outstanding 4.875% Senior Secured Notes due 2028 and 11.00% Senior Secured Notes due 2028 (the “11.00% Notes” and together with the 4.875% Notes, the “Existing… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Bausch Health Companies financials
Famous investors that hold BHC
5 of the 50 well-known investors we track reported holding BHC in their latest 13F filing. The largest position is Steve Cohen's, worth $19.3M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 3.31M | $19.3M | 0.0% | +48% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 2.17M | $12.6M | 0.0% | +96% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 2.06M | $12M | 0.0% | +55% |
| Israel Englander · Millennium Management | Q3 2026 | 1.31M | $7.6M | 0.0% | +19% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 942,585 | $5.5M | 0.0% | +9% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Bausch Health Companies Inc. (BHC) stock
Are BHC insiders buying or selling?
In the last 12 months, BHC insiders reported 1 open-market purchase worth $15.6M and 5 sales worth $507K. The latest trade was on Aug 19, 2026. See every trade.
What is the short interest in BHC?
As of Oct 30, 2026, 7.41M BHC shares were sold short, 2.0% of the shares outstanding, down 10.1% from the report before. At the average daily volume of 5.99M shares, buying them all back would take about 1.2 trading days (days to cover). See the history.
Which famous investors hold BHC?
5 of the 50 well-known investors we track reported BHC in their latest 13F filing, including Steve Cohen, Ken Griffin, Jim Simons. The largest position is worth $19.3M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.